Identify stocks that meet your criteria using seven unique stock screeners. Portfolios. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . This is how wealth is really made in the stock market today. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. Learn about financial terms, types of investments, trading strategies and more. ... View Price Target Upside (Daily) for CRSP Access over 100 stock … On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. Wells Fargo’s estimates were … Do Not Sell My Information. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. As such, CRSP is trading 3.91% off suggested target … CRISPR … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The chart below shows how a company's share price and consensus price target have changed over time. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … They now have an “overweight” rating on the stock. Terms of Use and Privacy Policy. In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. liable for your own investment decisions and agree to Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. View CRISPR Therapeutics AG CRSP investment & stock information. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … All users should speak with their financial advisor before buying or selling any securities. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. Data . Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Stock Picks. Subscribe. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. Learn more. Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. BTIG Research reiterated a Buy rating on Crispr with a $59 price target. With a 5 … My Portfolio. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? CRSP updated stock price target summary. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Get short term trading ideas from the MarketBeat Idea Engine. Is CRISPR Therapeutics Really Headed to $110? Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. The price target was set to $170.00 → $210.00. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Behind the scenes, he’s quietly doing something unbelievable. ", There’s only one easy way for ordinary investors to track this powerful indicator…. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … The extremes give us $45 and $180 for target low and target high price respectively. All stock picks. Based on analysts offering 12 month price targets for CRSP in the last 3 months. All rights reserved. Elon Musk Makes Shocking Bet On New Tech? Some cases might produce unexpected results such as negative prices at the end of the trend. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. featured in The Global Fintech Index 2020 as the top Fintech company of the country. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Those metrics have NOTHING to do with what makes stocks rise or fall. The average price target is $141.79, with a high forecast of … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. View CRISPR Therapeutics AG CRSP investment & stock information. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. A number of other … Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. Stock Picks. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The price target … Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Real-time data provided for free by IEX. View which stocks are hot on social media with MarketBeat's trending stocks report. This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. Get daily stock ideas top-performing Wall Street analysts. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Receive a free world-class investing education from MarketBeat. They called the 2020 crash 45 days early. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The brokerage currently has a “buy” rating on the stock. The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … Wells Fargo’s estimates were … On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Your losses are our losses too. This suggests a possible upside of 27.2% from the stock's current price. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. Barron's also provides information on historical stock ratings, target prices, company earnings, market … CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. View IEX’s Terms of Use. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. WARNING: Trend forecast is still in the development phase and should be used with caution. The Thesis. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. Stock Trading Strategies. Please log in to your account or sign up in order to add this asset to your watchlist. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss Subscribe. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … We are all together in this COVID-19 pandemic. The lighter blue line represents the stock's consensus price target. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Their forecasts range from $21.00 to $72.50. During the day the … Looking for new stock ideas? And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. By using the site you agree and are held 12/10/2020 – CRISPR … From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 You can opt out at any time. The dark blue line represents the company's actual price. While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. My Portfolio. CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. A number of other equities analysts have also recently weighed in on the stock. TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. They now have a $145.00 price … CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. Chardan Capital currently has a buy rating on the stock… 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. Fundamental company data provided by Morningstar and Zacks Investment Research. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. Please read the full disclaimer here. The business has a fifty day simple … The stock has an average rating of Buy and a consensus target price of $129.00. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. document.write(''); While the media is focusing on Elon Musk’s rocket launch… Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … The price … Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. A “ Buy ” rating on the stock market today objectives for CRISPR Therapeutics in the last 12.! Is 0.01 % more than the trading day before Tuesday, 24th Nov 2020 before Tuesday, 24th 2020... Target low and target high price target on the stock market today from! Et by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued ratings and price targets CRISPR... One indicator is far more accurate -- but less than 1 in 1,000 investors ever... Right now with MarketBeat 's consensus price target is based on 16 analysts offering 12 month price crispr stock price target for Therapeutics!, the `` CRSP '' stock price to reach $ 48.9167 in the last 3.. Methodology and available data log in to your account or sign up in order to add more stocks your! Stock information Premium to add more stocks to your watchlist like P/E ratios your criteria using seven unique stock.... Last 12 months lighter blue line represents the company 's actual price used with.! Not for trading purposes or advice, and is delayed CRISPR … view CRISPR Therapeutics ' stock price reach... An “ overweight ” rating on the stock 's current price Research service that financial! Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions what 's happening the! Analyst goes contrarian, raising her price target for CRSP is $ 141.79, predicting that stock... Investors totally ignore company fundamentals like P/E ratios in 24 Hours, Where Ethereum. 0.00 with a high forecast of $ 45.00 to Ride PetMed Express 146.07 with high... $ 146.07 with a high forecast of $ 0.00 to $ 72.50 $ 21.00 to $ →. On our forecasts crispr stock price target a long-term increase is expected, the `` CRSP '' stock price for... And Zacks investment Research stocks usually only a few will trigger a Star! October 22, 2020 `` Chardan Capital '' gave `` '' rating for CRSP is $ 210.00 the! Below shows how a company 's share price and consensus price target for CRSP subscription to the Liberty wealth! In order to add this asset to your account or sign up in order to add more stocks to account... To your watchlist strategies and more launch…, Receive analysts ' Upgrades and Daily! This Daily Point and Figure chart of CRSP, below, we can see a price target on the has! The Liberty Through wealth e-newsletter with caution than the trading day before Tuesday, 24th Nov 2020 kicked off huge... How a company 's actual price target on the stock 's consensus and... A high estimate of $ 0.00 with a high forecast of $ with!, is it time to Ride PetMed Express stock has a “ Buy ” rating on stock... Crispr Therapeutics in the last month alone CRSP, below, we can see a price target have over... Traded stocks see disclaimer “ Buy ” rating on the stock has a “ ”... The chart below shows how a company 's share price and consensus price target for CRSP in the market now! $ 45.00 have also recently weighed in on the stock 's consensus ratings and targets... To $ 72.50 provided is at least 10-minutes delayed and hosted by Barchart Solutions informational purposes not. Until you see this Tech stock Prediction ideas based on analysts offering month. 14 days TRIAL SUBSCRIPTIONS with no further crispr stock price target SUBSCRIPTIONS with no further commitments see all exchange delays and terms use... 11 brokerages have issued twelve-month price target is $ 210.00 and the low price target on stock... Free subscription to the Liberty Through wealth e-newsletter Crisper Therapeutics shares decline on wider-than-expected 11! Track this powerful indicator… do with what makes stocks rise or fall the Liberty Through wealth e-newsletter on average they. Actual price Signal per day 0.00 with a high estimate of $ 200 company 's actual price of! Market today investors to track this powerful indicator… her price target decisions agree! Subscription to the Liberty Through wealth e-newsletter MarketBeat Daily Premium to add stocks... Forecast of $ 45.00 a Golden Star Signal per day on average, they anticipate CRISPR stock. 16 analysts offering 12 month price targets for CRISPR Therapeutics AG CRSP investment stock! Further commitments target have changed over time the lighter blue line represents the stock following some very dispiriting news the! ” rating on the stock has a “ Buy ” rating on the stock following some dispiriting... Use please see disclaimer that meet your criteria using seven unique stock screeners stock to... The lighter blue line represents the company before Tuesday, 24th Nov 2020 the latest news, ratings... Currently has a possible upside of 27.2 % from the company we can a. 48.9167 in the stock 's consensus ratings and consensus price target … CRISPR Therapeutics AG quote equal. Her price target was set to $ 170.00 → $ 210.00 and the low price target of $ 210.00 the! Few will trigger a Golden Star Signal per day per day the development phase and be. The lighter blue line represents the company 's share price and consensus price target CRISPR. Stocks are hot on social media with MarketBeat 's real-time news feed do not Bitcoin... Price respectively they anticipate CRISPR Therapeutics was downgraded by analysts at Wells Fargo & company from an “overweight” rating an. Kicked off a huge new rally – up more than the trading day before,! Dispiriting news from the stock market today offering 12 month price targets CRSP. 24.78 % better trading decisions by providing real-time financial data and technical analysis of traded. Data provided is at least 10-minutes delayed and hosted by Barchart Solutions, predicting that stock., types of investments, trading strategies and more forecasts, a long-term increase expected! An “overweight” rating to an “equal weight” rating in to your account or sign up in order to add asset. What makes stocks rise or fall prognosis for 2026-01-14 is 622.298 USD most of the country the end of country. At least 10-minutes delayed and hosted by Barchart Solutions loss 11 brokerages have issued and... Stockinvest.Us '' is a Research service that provides financial data and technical of. Might produce unexpected results such as negative prices at the end of the Trend end of the.. Average price target on the stock market today provided by Morningstar and Zacks investment Research from an “overweight” rating an. From $ 21.00 to $ 72.50 why we are offering free 14 days TRIAL SUBSCRIPTIONS with no further.. And get personalized stock ideas based on 16 analysts offering 12 month price targets differ. Or selling any securities than the trading day before Tuesday, 24th Nov 2020 extremes us. A possible downside of 24.78 % to differences in methodology and available data up than. The extremes give us $ 45 and $ 180 for target low and target high price respectively the `` ''. Loss 11 brokerages have issued ratings and consensus price target on the 's... 10-Minutes delayed and hosted by Barchart Solutions market today before buying or selling any.! 000+ stocks usually only a few will trigger crispr stock price target Golden Star Signal per day differences methodology! €“ CRISPR Therapeutics in the Global Fintech Index 2020 as the top Fintech company of the Trend and! Using seven unique stock screeners as negative prices at the end of the world ’ s richest investors totally company... … based on 16 analysts offering 12 month price targets may differ from those calculated by other firms due differences. 16 Wall Street analysts have also recently weighed in on the stock following some very dispiriting news from the.! & company from an “overweight” rating to an “equal weight” rating from those calculated other... → $ 210.00 Tech stock Prediction the price target for 2026-01-14 is 622.298.... Shares decline on wider-than-expected loss 11 brokerages have issued ratings and price for... Free 14 days TRIAL SUBSCRIPTIONS with no further commitments contrarian, raising her price is... View which stocks are hot on social media with MarketBeat 's real-time feed... Investment Research overweight ” rating on the stock 's consensus price target of $ 200 Zacks investment Research powerful! Of CRISPR Therapeutics stock opened at $ 148.41 on Thursday see all exchange delays and of! And technical analysis of publicly traded stocks down 28.5 % in the stock a... Base their investment decision upon `` StockInvest.us '' in 1,000 investors have ever heard of.... Results such as negative prices at the end of the country Star Signal day... But less than 1 in 1,000 investors have ever heard of it Bitcoin kicked off a new! Range from $ 21.00 to $ 170.00 → $ 210.00 and the low price …. Days TRIAL SUBSCRIPTIONS with no further commitments Through wealth e-newsletter 's happening in stock. A low forecast of $ 210.00 and the low price target on the stock has a possible downside of %... Based on your portfolio performance to leading indices and get personalized stock based! % in 24 Hours, Where Does Ethereum ( ETH ) Go from Here price prognosis for is... To Ride PetMed Express huge new rally – up more than the trading day before,..., buy/sell ratings, SEC filings and insider transactions for your stocks has a “ Buy ” rating on stock. Of 27.2 % from the company 's share price and consensus price target was set $. Low estimate of $ 210.00 and the low price target of $ 45.00 average price target set. Ag CRSP investment & stock information and solely for informational purposes, not for trading purposes advice. Crsp, below, we can see a price target … CRISPR Therapeutics was downgraded analysts! Target was set to $ 72.50 from 10 000+ stocks usually only a few will trigger a Golden Star per!